Showing 361 - 380 results of 404 for search 'presented left ventricular function', query time: 0.12s Refine Results
  1. 361

    The MRI regional strain analysis in patients with hypertrophic cardiomyopathy by Esraa Maher, Magdi Khalil, Mona Taher, Sameh Khalil

    Published 2025-06-01
    “… Purpose: To evaluate the regional left ventricular myocardial strain in patient with hypertrophic cardiomyopathy (HCM) especially young apparently compensated patients by magnetic resonance imaging. …”
    Get full text
    Article
  2. 362

    A novel, non-invasive AI-based telemonitoring system for heart failure: detection of undiagnosed hyperthyroidism in an asymptomatic patient by Allan Böhm, Julia Lucka, Amitai Segev, Marta Kollarova, Stefan Toth, Nikola Jajcay, Branislav Bezak

    Published 2025-07-01
    “…We have developed a non-invasive method to assess left ventricular filling pressures (LVFP) by analysing the photoplethysmography signal with Seeling HeartCore technology (Seerlinq, Bratislava, Slovakia). …”
    Get full text
    Article
  3. 363

    The Role of SGLT2-Inhibitors Across All Stages of Heart Failure and Mechanisms of Early Clinical Benefit: From Prevention to Advanced Heart Failure by Simone Pasquale Crispino, Andrea Segreti, Vincenzo Nafisio, Daniele Valente, Filippo Crisci, Aurora Ferro, Ilaria Cavallari, Annunziata Nusca, Gian Paolo Ussia, Francesco Grigioni

    Published 2025-03-01
    “…Sodium-glucose cotransporter-2 inhibitors (SGLT2i), initially developed as antihyperglycemic agents, have revolutionized heart failure (HF) management, offering substantial benefits across all stages and phenotypes of the disease. Regardless of left ventricular ejection fraction (LVEF), these agents have proven efficacy in both chronic and acute HF presentations. …”
    Get full text
    Article
  4. 364

    Validation of the echoSHOCK protocol for diagnosing the cause of shock in patients arriving at the emergency department by Takshak Shankar, Nidhi Kaeley, Parvathy Sasidharan, Archana Bairwa, M. S. Salva Ameena, Sreejith Jayachandran, Jewel Rani Jose, Jitendra Kumar Yadav

    Published 2025-04-01
    “…The protocol used a phased array probe in B-mode solely and assessed left ventricle function, compressive pericardial effusion, right ventricular dilatation, interventricular septum flattening, and indicators of hypovolemia. …”
    Get full text
    Article
  5. 365

    ANTITHROMBOTIC THERAPY IN PREVENTION OF CARDIOVASCULAR EVENTS (DEATH, ACUTE MYOCARDIAL INFARCTION, STROKE) IN PATIENTS WITH CHRONIC HEART FAILURE by N.D. Gerasimenko, M.S. Rasin

    Published 2017-12-01
    “…The results of controlled trials recommend anticoagulant therapy for patients with heart failure who are at high risk, particularly in atrial fibrillation, with previous thromboembolic episodes, a significant reduction in the left ventricular ejection fraction, intracardiac thrombosis and in patients with aneurysm. …”
    Get full text
    Article
  6. 366

    Randomised placebo-controlled trial of combination ACE inhibitor and beta-blocker therapy to prevent cardiomyopathy in children with Duchenne muscular dystrophy? (DMD Heart Protect... by John P Bourke, Gillian Watson, Francesco Muntoni, Stefan Spinty, Helen Roper, Michela Guglieri, Chris Speed, Elaine McColl, Ashish Chikermane, Sandeep Jayawant, Satish Adwani, Tracey Willis, Jennifer Wilkinson, Andrew Bryant, Thomas Chadwick, Ruth Wood, Kate Bushby

    Published 2018-12-01
    “…Fundamental questions remain as to whether prophylactic therapy is justified and convincingly superior to prompt deployment of the same therapies once left ventricular (LV) dysfunction is detected. Even if it were, at what age should therapy be introduced and with what specific drugs?…”
    Get full text
    Article
  7. 367
  8. 368

    Early onset development of hypertrophic cardiomyopathy in less than 1 year in a patient with familial Friedrich's ataxia: Case report by Yasmine Ouaddouh, MD, Salma Bouyaddid, MD, Zakaria Bazid, MD, PhD, Nabila Ismaili, MD, PhD, Noha El Ouafi, MD, PhD

    Published 2025-06-01
    “…However, a transthoracic echocardiography demonstrated nonobstructive hypertrophic cardiomyopathy with a maximal wall thickness of 20 mm, incomplete anterior systolic motion of the mitral valve, a significant development in less than 1 year after last normal cardiac assessment. Left ventricular systolic function was preserved (ejection fraction 50%). …”
    Get full text
    Article
  9. 369

    Early Use of Liraglutide for the Treatment of Acute COVID-19 Infection: An Open-Label Single-Center Phase II Safety Study with Biomarker Profiling by Eloara V. M. Ferreira, Rudolf K. F. Oliveira, Reinaldo Salomao, Milena K. C. Brunialti, Martyella B. A. Cardoso, Chien-nien Chen, Lan Zhao, Colm McCabe

    Published 2025-01-01
    “…Patients with milder COVID-19 pneumonia severity also demonstrated improvement in echocardiographic parameters of right and left ventricular function, reduction in plasma Troponin levels, increased CD147 expression on T lymphocytes, and reduction in plasma IL-8. …”
    Get full text
    Article
  10. 370

    Clinical Characteristics and Outcomes of Takotsubo Syndrome Patients with Gastrointestinal Diseases: A Systematic Review by Jiaming Guo, Yiran Zhang, Xiaoyu Jiang, Huinan Wang, Yaohan Guo, Yuxin Fan, Cai Peng, Catherine Teng, Ao Shi, Xiaojia Lu, Jianjun Ma, Man Dong, Pengyang Li

    Published 2025-02-01
    “…Background: Takotsubo syndrome (TTS) is identified by its acute and transient impairment of left ventricular systolic function. Although recent research has highlighted occurrences of TTS among individuals with gastrointestinal diseases (GI diseases), comprehensive and systematic investigations focusing on this patient demographic are still scarce. …”
    Get full text
    Article
  11. 371

    Comparison of efficacy and safety of His-Purkinje system pacing versus cardiac resynchronisation therapy in patients with pacing-induced cardiomyopathy: protocol for a randomised c... by Junjun Chen, Liting Cheng, Junmeng Zhang, Zefeng Wang, Zhuo Liang, Jieruo Chen, Yongquan Wu, Xiao Du, Ruiqing Dong, Fei Hang, Xinlu Wang, Ziyu Wang

    Published 2021-08-01
    “…The primary outcome is the duration of QRS complex (QRS width), and the secondary outcomes are NT-proBNP (N terminal pro B type natriuretic peptide), C reactive protein, the number of antibiotics used, left ventricular ejection fraction, end systolic volume, end diastolic volume, the hospitalisation duration, the incidence of postoperative infection, pacemaker parameters (threshold, sensing and impedance), the 6-minute walking test, and quality of life (36-Item Short Form Survey scale), all-cause mortality, cardiovascular death, heart failure-related rehospitalisation rate, other rehospitalisation rates, major complication rates and procedure costs.Ethics and dissemination This study has been approved by the Beijing Anzhen Hospital Medical Ethics Committee (No. 2020043X).Trial registration number Chinese Clinical Trial Registry (ChiCTR2000034265).…”
    Get full text
    Article
  12. 372

    Allopurinol in the complex therapy of acute decompensation of heart failure by Laura H. Sarieva, Marina D. Muksinova, Svetlana N. Nasonova, Igor V. Zhirov, Sergey N. Tereshchenko

    Published 2025-01-01
    “…The analysis of echocardiographic parameters revealed a significantly increased left ventricular ejection fraction, a reduction in inferior vena cava size, and a decrease in systolic pressure in the pulmonary artery in both groups. …”
    Get full text
    Article
  13. 373
  14. 374

    Effects of exercise based cardiac rehabilitation delivery modes on chronic heart failure: a systematic review and network meta-analysis by Chen Hua, Wenrui Huang, Zhen Chen, Dongmei Cao, Juan Jia, Xiaomei Chen, Juan Yang, Limin Zhang

    Published 2024-12-01
    “…Center-based cardiac rehabilitation (CBCR) with high-intensity interval training (HIIT) was the most effective in enhancing left ventricular ejection fraction (LVEF), while CBCR(AE) demonstrated the greatest improvement in peak oxygen uptake (Peak VO2) [RR = 3.64, 95% CI: 1.66–7.95]. …”
    Get full text
    Article
  15. 375

    Prevalence, correlative and statistical relationships of renal dysfunction in patients with chronic ischemic heart failure by D. A. Lashkul

    Published 2014-02-01
    “…The perspective is to further explore the prognostic significance of the detected change, the possibility of pharmacological correction in patients with ischemic chronic heart failure, depending on age, sex, functional class, left ventricular contractile ability.…”
    Get full text
    Article
  16. 376
  17. 377

    Twenty-year changes in the clinical and echocardiographic characteristics of patients with early postinfarction remodeling after primary ST-segment elevation myocardial infarction by A. M. Nikolaeva, T. R. Ryabova, A. A. Sokolov, V. V. Ryabov

    Published 2023-01-01
    “…To compare structural and functional left ventricular (LV) changes in the early period of myocardial infarction (MI) within 20 years on the basis of the Emergency Cardiology Department of the Cardiology Research Institute (Tomsk).Material and methods. …”
    Get full text
    Article
  18. 378

    From bench to bedside: elucidating VEGF(R) inhibitor-related heart failure in cancer treatment by Shengkun Peng, MinHong Cai, Hongyu Kuang, Anqi Lin, Qinghua Ma, Xiaoqin Dai, Peng Luo, Yijun Liu, Guo Zhang, Yifeng Bai

    Published 2025-01-01
    “…Experimental studies in mice revealed that both acute and chronic VEGF(R)i administration resulted in reduced left ventricular EF, cardiomyocyte hypertrophy, and myocardial fibrosis. …”
    Get full text
    Article
  19. 379

    Type I primary neuropathic amyloidosis (Andrade, Portuguese): a clinical and laboratory study of 21 cases by Eduardo M. Azevedo, Milberto Scaff, Horacio M. Canelas, Antonio Spina-França

    Published 1975-06-01
    “…The electrocardiography showed repolarization disorders in 11 cases, left ventricular overload in 6 cases and atrioventricular block in 5 cases. …”
    Get full text
    Article
  20. 380

    Influence of angiotensin II type 1 receptors and angiotensin-converting enzyme I/D gene polymorphisms on the progression of Chagas' heart disease in a Brazilian cohort: Impact of t... by Thayse do Espírito Santo Protásio da Silva, Lucia Elena Alvarado-Arnez, Angelica Martins Batista, Silvia Marinho Martins Alves, Gloria Melo, Cristina Veloso Carrazzone, Isabelle de Oliveira Moraes, Antonio G Pacheco, Camila Sarteschi, Milton Ozório Moraes, Wilson Oliveira, Joseli Lannes-Vieira

    Published 2024-11-01
    “…One-third of CD patients develop cardiac disease (CARD), an inflammatory and fibrotic process that may progress to heart failure associated with reduced left ventricular ejection fraction (LVEF). The determinants of CD progression are still uncertain. …”
    Get full text
    Article